Hightide Therapeutics Inc (HK:2511) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
HighTide Therapeutics Inc. has announced a change in its joint company secretary position, with Ms. Gao Liping taking over the role from Ms. Yu Li as of December 19, 2024. While Ms. Gao lacks the formal qualifications typically required, the company has received a waiver from the Hong Kong Stock Exchange due to her extensive experience and familiarity with the company’s operations. This strategic move underscores HighTide’s commitment to leveraging internal talent to support its growth in the pharmaceutical sector.
For further insights into HK:2511 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue